The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Camrelizumab plus apatinib in patients with advanced cervical cancer: A multicenter, open-label, single-arm, phase II trial.
 
Chunyan Lan
No Relationships to Disclose
 
Xin Huang
Research Funding - Jiangsu Hengrui Medicine
 
Jing-Xian Shen
No Relationships to Disclose
 
Yin Wang
No Relationships to Disclose
 
Ying Xiong
No Relationships to Disclose
 
Jundong Li
No Relationships to Disclose
 
Xinping Cao
No Relationships to Disclose
 
Yanhong Deng
No Relationships to Disclose
 
Mian He
No Relationships to Disclose
 
Guorong Zou
No Relationships to Disclose
 
Xiaodi Wang
Employment - Jiangsu Hengrui Medicine
Stock and Other Ownership Interests - Jiangsu Hengrui Medicine
Travel, Accommodations, Expenses - Jiangsu Hengrui Medicine